Eli Lilly applies for emergency use of antibody drug for COVID-19
The drugmaker said its two-antibody cocktail helped reduce viral levels more than the single antibody treatment had in a prior study. "We believe that Lilly's data provides some real evidence that the combo mAb (monoclonal antibody) approach may provide meaningful clinical benefits," Baird

Full story is loading. Click here if it doesn't...